Andy Xu, PharmD, is currently an Associate Principal Scientist in Late Stage Clinical Development at Merck. They previously served as an Adjunct Faculty at Rutgers University and completed a post-doctoral fellowship in Translational Pharmacology at Merck. Andy has also held roles as a Scientist and Lab Associate at Primera Analytical Solutions Corporation, where they led and conducted various analytical projects using advanced techniques. They began their career as a QC Assay Validation Intern at Regeneron Pharmaceuticals, where they developed methods for detecting drug candidates. Andy holds a Doctor of Pharmacy degree from Rutgers University-New Brunswick, earned in 2019.
This person is not in any teams
This person is not in any offices